/Companies

Vetstem

1 known investors

Find your way into Vetstem

Sign up to see every warm intro you have to Vetstem

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Vetstem team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

VETSTEM develops regenerative cell therapies based on multipotent mesenchymal stem cells (MSCs) and high-bioavailability pharmaceutical products for treating diseases in pets. The company operates in veterinary biotech, applying molecular-cell technologies and pharmaceutical chemistry to animal health.

Investors · 1

Frequently asked questions

What does Vetstem do?
VETSTEM develops regenerative cell therapies based on multipotent mesenchymal stem cells (MSCs) and high-bioavailability pharmaceutical products for treating diseases in pets. The company operates in veterinary biotech, applying molecular-cell technologies and pharmaceutical chemistry to animal health.
Who are Vetstem's investors?
Vetstem's investors include Moscow Venture Fund (formerly Moscow Seed Fund).